Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

815
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
815
Long-term Depression01:05

Long-term Depression

33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal trajectories of depressive symptoms in children are associated with baseline inflammation and HIV status.

Communications health·2026
Same author

Game-based Cognitive Training for School-age Children Living With or Exposed to HIV: A Randomized Controlled Trial in Uganda and Malawi.

Journal of developmental and behavioral pediatrics : JDBP·2026
Same author

Dementia etiology classification using NULISA plasma biomarkers and machine learning.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

County-Level Contributors to Geographic Variation in Medicare Fee-for-Service Stroke Hospitalization Rates: A Cross-Sectional Study.

Journal of the American Heart Association·2026
Same author

Plasma neurofilament light is associated with hippocampal volume and memory performance but not functional connectivity in older adults with and without mild cognitive decline.

Aging brain·2026
Same author

Linking sleep apnea and arthritis in the National Alzheimer Coordinating Center Cohort: A cross-sectional analysis.

Medicine·2026

Related Experiment Video

Updated: Mar 7, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Executive Functioning at Baseline Prospectively Predicts Depression Treatment Response.

Erica L Dawson1, Angela F Caveney1, Kortni K Meyers1

  • 1Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, Michigan, USA.

The Primary Care Companion for CNS Disorders
|February 15, 2017
PubMed
Summary

Cognitive markers, specifically processing speed with interference resolution, can predict depression treatment response. These executive functioning assessments may help identify patients at risk for not responding to standard treatments.

More Related Videos

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

11.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

11.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Area of Science:

  • Neuroscience
  • Clinical Psychology
  • Psychiatry

Background:

  • Predicting treatment response in depression is crucial for effective clinical decision-making.
  • Existing predictors lack sufficient strength and clinical utility.
  • This study explored clinical and cognitive markers for predicting treatment outcomes in depressed adults.

Purpose of the Study:

  • To investigate the predictive power of clinical and cognitive markers for treatment response in depressed adults.
  • To assess if executive functioning assessments can identify individuals at risk for poor treatment outcomes.

Main Methods:

  • A sample of 75 depressed adults receiving standard treatment (medication and psychotherapy) was studied.
  • Clinical data, including baseline Patient Health Questionnaire (PHQ-9) scores and education, were collected.
  • Computerized neuropsychological tests, including the Parametric Go/No-Go task, assessed cognitive functions.

Main Results:

  • A 46% decline in PHQ-9 scores was observed at follow-up, with 56% of patients classified as responders.
  • Baseline PHQ-9 scores and education predicted treatment response.
  • Faster processing speed with interference resolution (go reaction time) significantly predicted treatment outcomes, accounting for 12% of the variance.

Conclusions:

  • Executive functioning assessments, particularly processing speed, can aid in identifying depressed individuals likely to respond to standard treatments.
  • Integrating cognitive assessments into clinical practice may improve treatment selection and patient outcomes.